Jonathan W.t Ayers, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3145 W Clark Rd, Suite 301, Ypsilanti, MI 48197 Phone: 734-434-4766 |
Tamika L Martin, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4936 W Clark Rd Ste 100, Ypsilanti, MI 48197 Phone: 734-434-6200 Fax: 734-434-7373 |
Dr. Susanne Archer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4940 W Clark Rd, Suite 100, Ypsilanti, MI 48197 Phone: 734-434-0477 Fax: 734-434-6240 |
Dr. Gayle Moyer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4936 W Clark Rd, Building D, Suite 100, Ypsilanti, MI 48197 Phone: 734-434-6200 Fax: 734-434-7373 |
Deborah Lynn Landis Lewis, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5333 Mcauley Dr, Suite 2110, Ypsilanti, MI 48197 Phone: 734-712-3967 Fax: 734-712-2341 |
Dr. James Marley, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4940 W Clark Rd, Suite 100, Ypsilanti, MI 48197 Phone: 734-434-0477 Fax: 734-434-6240 |
News Archive
To best cope with terminal hemorrhage, at-risk patients should be identified by healthcare professionals while their families and caregivers are prepared, supported, and instructed to assure, be there for, and calm and comfort the patient as the event occurs, say researchers.
The Wall Street Journal: "Fourteen states plus the District of Columbia have passed laws intended to give certain ill people legal access to medical marijuana. But, in many instances, municipalities are left to figure out how to implement state laws that are often vague when it comes to the day-to-day operations of the medical-pot business. Those laws have led to confusion in communities and pushed states including Colorado and Maine to clarify what is legal for the industry."
Researchers have identified measures early in the course of chronic graft-versus-host disease that predict long-term prognosis in haematopoietic cell transplantation recipients.
Urodynamix Technologies Ltd. (TSX VENTURE:URO) today reported its financial results for its fiscal second quarter ended June 30, 2009. The Company reported revenues of $21,871, a 70% decrease over the same quarter of the prior year. The Company's order backlog at June 30, 2009 was $92,576 compared to nil at the end of the comparative quarter June 30, 2008.
› Verified 9 days ago